Palivizumab (Synagis; MedImmune/Abbott) is a humanized murine monoclonal antibody against the RSV fusion protein that prevents the spread of virus to the lower respiratory tract 2. It was approved ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback